Home › New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug
 

Keywords :   


New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug

2013-10-14 06:06:15| Biotech - Topix.net

A New Zealand biotechnology company, CuroNZ, received funding from the US National Multiply Sclerosis Society worth $540,000 to be used in pre-clinical studies.

Tags: multiple firm drug zealand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
06.10Hurricane Leslie Wind Speed Probabilities Number 15
06.10Hurricane Leslie Public Advisory Number 15
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Leslie Forecast Advisory Number 15
06.10Hurricane Kirk Forecast Discussion Number 27
More »